Table 3.
Relationship Between Cytoplasmic CD24 Expression and Various Clinicopathological Factors in All Patients with Invasive Ovarian Carcinoma
| Characteristic | All cases | Cytoplasmic CD24-negative | Cytoplasmic CD24-positive | Significance |
|---|---|---|---|---|
| All carcinomas | 56 (100%) | 23 (41.1%) | 33 (58.9%) | |
| Age at surgery (years) | 0.422* | |||
| ≤60 | 30 (100%) | 14 (46.7%) | 16 (53.3%) | |
| >60 | 26 (100%) | 9 (34.6%) | 17 (65.4%) | |
| Histological grade (Silverberg) | 0.184† | |||
| G1 | 11 (100%) | 7 (63.6%) | 4 (36.4%) | |
| G2 | 23 (100%) | 7 (30.4%) | 16 (69.6%) | |
| G3 | 22 (100%) | 9 (40.9%) | 13 (59.1%) | |
| Histological type | 0.385† | |||
| Serous | 29 (100%) | 14 (48.3%) | 15 (51.7%) | |
| Undifferentiated | 12 (100%) | 3 (25%) | 9 (75%) | |
| Non-serous | 15 (100%) | 6 (40%) | 9 (60%) | |
| pT | 0.934† | |||
| pT1 | 11 (100%) | 5 (45.5%) | 6 (54.5%) | |
| pT2 | 7 (100%) | 3 (42.9%) | 4 (57.1%) | |
| pT3 | 38 (100%) | 15 (39.5%) | 23 (60.5%) | |
| pN | 0.725* | |||
| pN0 | 14 (100%) | 7 (50%) | 7 (50%) | |
| pN1 | 17 (100%) | 7 (41.2%) | 10 (58.8%) | |
| pM | 0.636* | |||
| pMX | 52 (100%) | 22 (42.3%) | 30 (57.7%) | |
| pM1 | 4 (100%) | 1 (25%) | 3 (75%) | |
| FIGO stage | 0.823† | |||
| I | 10 (100%) | 5 (50%) | 5 (50%) | |
| II | 6 (100%) | 2 (33.3%) | 4 (66.7%) | |
| III | 36 (100%) | 15 (41.7%) | 21 (58.3%) | |
| IV | 4 (100%) | 1 (25%) | 3 (75%) |
*Fisher’s test.
†χ2 test.